Extraordinary response of metastatic pancreatic cancer to apatinib after failed chemotherapy: A case report and literature review
Cheng-Ming Li, Zhi-Chao Liu, School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Sciences, Jinan 250101, Shandong Province, China
Cheng-Ming Li, Zhi-Chao Liu, You-Ting Bao, Xin-Dong Sun, Lin-Lin Wang, Department of Radiation Oncology, Shandong Cancer Hospital Affiliated to Shandong University, Shandong Academy of Medical Sciences, Jinan 250117, Shandong Province, China
You-Ting Bao, Department of Oncology, Weifang Medical University, Weifang 261042, Shandong Province, China
Lin-Lin Wang, School of Medicine, Shandong University, Jinan 250012, Shandong Province, China
Author contributions: Li CM collected the case data and wrote the paper; Sun XD and Wang LL treated the patient; Li CM, Liu ZC and Bao YT contributed to the literature search; Wang LL reviewed and revised the manuscript; All authors have read and approved the final manuscript.
Supported by The National Natural Science Foundation of China, No. 81402299; the Project of Postdoctoral Innovation of Shandong Province, No. 201501010; and the Project of Postdoctoral Science Foundation of China, No. 2016M590640.
Institutional review board statement: The case report was reviewed and approved by the Institutional Review Board of Shandong Cancer Hospital Affiliated to Shandong University, Jinan, China.
Informed consent statement: The husband of the patient provided written informed consent.
Conflict-of-interest statement: All the authors declare that there is no conflict of interest.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Lin-Lin Wang, MD, PhD, Department of Radiation Oncology, Shandong Cancer Hospital Affiliated to Shandong University, Shandong Academy of Medical Sciences, No. 440, Jiyan Road, Jinan 250117, Shandong Province, China. firstname.lastname@example.org
Telephone: +86-531-67626142 Fax: +86-531-67626141
Received: July 14, 2017
Peer-review started: August 1, 2017
First decision: August 31, 2017
Revised: September 13, 2017
Accepted: September 26, 2017
Article in press: September 26, 2017
Published online: November 7, 2017